Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Kewaunee Scientific (KEQU) over the last 15 years, with Q4 2025 value amounting to $22.7 million.

  • Kewaunee Scientific's Accounts Payables rose 560.16% to $22.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $22.7 million, marking a year-over-year increase of 560.16%. This contributed to the annual value of $27.0 million for FY2025, which is 1621.1% up from last year.
  • Latest data reveals that Kewaunee Scientific reported Accounts Payables of $22.7 million as of Q4 2025, which was up 560.16% from $26.3 million recorded in Q3 2025.
  • Kewaunee Scientific's Accounts Payables' 5-year high stood at $27.4 million during Q1 2022, with a 5-year trough of $16.0 million in Q1 2021.
  • Moreover, its 5-year median value for Accounts Payables was $22.9 million (2022), whereas its average is $22.4 million.
  • As far as peak fluctuations go, Kewaunee Scientific's Accounts Payables skyrocketed by 7138.66% in 2022, and later crashed by 2340.45% in 2024.
  • Kewaunee Scientific's Accounts Payables (Quarter) stood at $20.2 million in 2021, then rose by 13.95% to $23.0 million in 2022, then fell by 16.82% to $19.2 million in 2023, then rose by 11.92% to $21.5 million in 2024, then grew by 5.6% to $22.7 million in 2025.
  • Its Accounts Payables stands at $22.7 million for Q4 2025, versus $26.3 million for Q3 2025 and $27.0 million for Q2 2025.